French Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow.
https://european-biotechnology.com/wp-content/uploads/2024/04/Abivax.jpg500839Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-22 21:48:132024-07-12 12:52:31Abivax SA raises €130m to advance obefazimod to Phase III
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Mark_Chadwick_Ingenza_kl.jpg12501245Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-02-22 11:14:322024-07-16 17:18:00Ingenza gets a new strategic business advisor
https://european-biotechnology.com/wp-content/uploads/2024/04/Devonyu.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-21 15:27:362024-07-12 12:51:14Paleo raised € 12 m in Series A financing round
https://european-biotechnology.com/wp-content/uploads/2024/04/RS5629_AdobeStock_127114772-scr.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-21 09:30:422024-07-12 12:49:16Minaris and LIfT BioSciences collaborate in cell therapy development
France-based Abivax SA announced the appointment of Sheldon Sloan, M.D., M. Bioethics, as its new Chief Medical Officer. He will assume the new role in the beginning of March.
PVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre.
A UK Biobank study suggests that higher intake of free sugars is associated with a higher risk to develop cardiovascular disease, UK researchers report in BMC Medicine.
https://european-biotechnology.com/wp-content/uploads/2024/04/Expansion_of_the_Munich.png540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-15 10:42:062024-06-21 14:05:29Expansion of the Munich science line has started
Fermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins.
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2023-02-14_um_17.00.23.png459971Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-15 06:01:002024-07-15 12:38:25AMsilk scaling up through Evonik collaboration
High blood pressure reprograms immune system
Latest NewsInterferon-gamma overexpression leads to hypertension-induced damage to the blood-brain barrier by reprogrammed macrophages.
Abivax SA raises €130m to advance obefazimod to Phase III
Latest NewsFrench Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow.
Ingenza gets a new strategic business advisor
AppointmentsDr Mark Chadwick will bring extensive industry knowledge to his new role as Strategic Business Advisor at UK-based Ingenza Ltd.
Paleo raised € 12 m in Series A financing round
Latest NewsMyoglobin producer Paleo NV has closed a € 12 m Series A round led by DSM Venturing and Planet A Ventures.
Minaris and LIfT BioSciences collaborate in cell therapy development
Latest NewsCDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences.
Abivax appoints new CMO
AppointmentsFrance-based Abivax SA announced the appointment of Sheldon Sloan, M.D., M. Bioethics, as its new Chief Medical Officer. He will assume the new role in the beginning of March.
PVH Corp joins fiber-to-fiber consortium
Latest NewsPVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre.
Free sugar linked to higher cardiovascular disease
Latest NewsA UK Biobank study suggests that higher intake of free sugars is associated with a higher risk to develop cardiovascular disease, UK researchers report in BMC Medicine.
Expansion of the Munich science line has started
BackgroundThe extension, which was celebrated with an official groundbreaking ceremony, will connect the IZB campus in Martinsried to the Munich subway system.
AMsilk scaling up through Evonik collaboration
Latest NewsFermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins.